Investigating the healthcare resource utilization associated with complicated urinary tract infections in three phase 3 trials for ceftazidime-avibactam

Mapping Intimacies ◽

10.26226/morressier.56d6be72d462b80296c971f0 ◽

2016 ◽

Author(s):

Kellie Ryan

Keyword(s):

Urinary Tract ◽

Resource Utilization ◽

Urinary Tract Infections ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Phase 3 ◽

Three Phase ◽

Tract Infections

Get full-text (via PubEx)

Descriptive Analysis of Healthcare Resource Utilization and Costs Associated with Treatment of Urinary Tract Infections in United States Hospitals

American Journal of Infection Control ◽

10.1016/j.ajic.2021.04.009 ◽

2021 ◽

Vol 49 (6) ◽

pp. S2

Author(s):

Jennifer Judy ◽

Dorothy Baumer ◽

Christina Khoo

Keyword(s):

United States ◽

Urinary Tract ◽

Resource Utilization ◽

Urinary Tract Infections ◽

Healthcare Resource ◽

Descriptive Analysis ◽

Healthcare Resource Utilization ◽

Tract Infections

Get full-text (via PubEx)

Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma

Journal of Medical Economics ◽

10.1080/13696998.2018.1474745 ◽

2018 ◽

Vol 21 (8) ◽

pp. 793-798 ◽

Cited By ~ 4

Author(s):

Parameswaran Hari ◽

Huamao Mark Lin ◽

Yanyan Zhu ◽

Deborah Berg ◽

Paul G. Richardson ◽

...

Keyword(s):

Multiple Myeloma ◽

Resource Utilization ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Phase 3 ◽

Double Blind ◽

Refractory Multiple Myeloma

Get full-text (via PubEx)

Beta-lactamase characterization of baseline Enterobacteriaceae from phase 3 trials of ceftazidime-avibactam (CAZ-AVI) for the treatment of complicated urinary tract infections (cUTIs)

10.26226/morressier.56d6be7ad462b80296c97cea ◽

2016 ◽

Author(s):

Rodrigo E. Mendes

Keyword(s):

Urinary Tract ◽

Urinary Tract Infections ◽

Beta Lactamase ◽

Phase 3 ◽

Tract Infections

Get full-text (via PubEx)

PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma

Value in Health ◽

10.1016/j.jval.2020.08.177 ◽

2020 ◽

Vol 23 ◽

pp. S428

Author(s):

M. Mandala ◽

A. Arance ◽

R. Dummer ◽

P.A. Ascierto ◽

H. Gogas ◽

...

Keyword(s):

Metastatic Melanoma ◽

Resource Utilization ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Phase 3 ◽

Braf Mutant

Get full-text (via PubEx)

UROLOGIC DISEASES IN NORTH AMERICA PROJECT: TRENDS IN RESOURCE UTILIZATION FOR URINARY TRACT INFECTIONS IN CHILDREN

The Journal of Urology ◽

10.1097/01.ju.0000152092.03931.9a ◽

2005 ◽

Vol 173 (3) ◽

pp. 949-954 ◽

Cited By ~ 76

Author(s):

ANDREW L. FREEDMAN ◽

Keyword(s):

Urinary Tract ◽

North America ◽

Resource Utilization ◽

Urinary Tract Infections ◽

Urologic Diseases ◽

Tract Infections

Get full-text (via PubEx)

Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

Open Forum Infectious Diseases ◽

10.1093/ofid/ofx163.1396 ◽

2017 ◽

Vol 4 (suppl_1) ◽

pp. S536-S536 ◽

Cited By ~ 1

Author(s):

Thomas J Walsh ◽

Tanaya Bhowmick ◽

Rabih Darouiche ◽

Valerii Zaitsev ◽

Evangelos Giamarellos-Bourboulis ◽

...

Keyword(s):

Urinary Tract ◽

Urinary Tract Infections ◽

Acute Pyelonephritis ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Blind Trial ◽

Trial Outcomes ◽

Tract Infections

Get full-text (via PubEx)

Meropenem-Vaborbactam (M-V) Compared With Piperacillin-Tazobactam (P-T) in the Treatment of Adults With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in a Phase 3 Randomized, Double-Blind, Double-Dummy Trial (TANGO 1)

Open Forum Infectious Diseases ◽

10.1093/ofid/ofw195.07 ◽

2016 ◽

Vol 3 (suppl_1) ◽

Cited By ~ 6

Author(s):

Jeff Loutit ◽

Karen Fusaro ◽

Shu Zhang ◽

Elizabeth Morgan ◽

Elizabeth Alexander ◽

...

Keyword(s):

Urinary Tract ◽

Urinary Tract Infections ◽

Acute Pyelonephritis ◽

Phase 3 ◽

Double Blind ◽

Tract Infections

Get full-text (via PubEx)

Healthcare resource utilization in a phase 3 study of CPX-351 in patients with newly diagnosed high-risk/secondary acute myeloid leukemia

Journal of Medical Economics ◽

10.1080/13696998.2020.1744613 ◽

2020 ◽

Vol 23 (7) ◽

pp. 714-720

Author(s):

Kathleen F. Villa ◽

Robert J. Ryan ◽

Michael Chiarella ◽

Arthur C. Louie

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Resource Utilization ◽

Myeloid Leukemia ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Newly Diagnosed ◽

Phase 3 ◽

Secondary Acute Myeloid Leukemia ◽

Acute Myeloid

Get full-text (via PubEx)

1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis)

Open Forum Infectious Diseases ◽

10.1093/ofid/ofy210.1640 ◽

2018 ◽

Vol 5 (suppl_1) ◽

pp. S576-S577

Author(s):

Mohd Amin Mir ◽

Saransh Chaudhary ◽

Manu Chaudhary ◽

Anurag Pyasi ◽

N S Patil ◽

...

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Urinary Tract Infections ◽

Acute Pyelonephritis ◽

Phase 3 ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Tract Infections ◽

Genotypic Profile

Get full-text (via PubEx)

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases ◽

10.1093/cid/ciw378 ◽

2016 ◽

Vol 63 (6) ◽

pp. 754-762 ◽

Cited By ~ 147

Author(s):

Florian M. Wagenlehner ◽

Jack D. Sobel ◽

Paul Newell ◽

Jon Armstrong ◽

Xiangning Huang ◽

...

Keyword(s):

Urinary Tract ◽

Randomized Trial ◽

Urinary Tract Infections ◽

Acute Pyelonephritis ◽

Phase 3 ◽

Tract Infections

Get full-text (via PubEx)